E C Bradley

1.1k total citations
17 papers, 878 citations indexed

About

E C Bradley is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, E C Bradley has authored 17 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Immunology and 2 papers in Surgery. Recurrent topics in E C Bradley's work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). E C Bradley is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). E C Bradley collaborates with scholars based in United States and Canada. E C Bradley's co-authors include Nitin K. Damle, Laura V. Doyle, J R Bender, Joaquín S. Aldrete, Raymond A. Kempf, William D. Boswell, W. Harel, M S Mitchell, Hungyi Shau and Stuart E. Lind and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

E C Bradley

17 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E C Bradley United States	11	423	409	153	120	116	17	878
David Z. Chang United States	14	776 1.8×	357 0.9×	339 2.2×	98 0.8×	114 1.0×	19	1.3k
T Yoshikubo Japan	9	453 1.1×	127 0.3×	168 1.1×	29 0.2×	64 0.6×	16	765
Ernest Marshall United Kingdom	17	482 1.1×	209 0.5×	287 1.9×	30 0.3×	40 0.3×	42	938
Roopinder Gillmore United Kingdom	15	684 1.6×	210 0.5×	176 1.2×	367 3.1×	322 2.8×	49	1.3k
Christian Teschendorf Germany	12	222 0.5×	75 0.2×	182 1.2×	66 0.6×	75 0.6×	28	621
Jeltje F. de Vries Netherlands	10	747 1.8×	225 0.6×	122 0.8×	32 0.3×	80 0.7×	15	1.2k
Pilar Lardelli Spain	19	643 1.5×	135 0.3×	298 1.9×	276 2.3×	102 0.9×	71	1.5k
Hong Xie United States	13	406 1.0×	138 0.3×	338 2.2×	24 0.2×	135 1.2×	29	739
Hideaki Mabuchi Japan	17	290 0.7×	262 0.6×	383 2.5×	27 0.2×	280 2.4×	33	1.1k
Nicola Calvani Italy	16	382 0.9×	296 0.7×	325 2.1×	26 0.2×	22 0.2×	46	911

Countries citing papers authored by E C Bradley

Since Specialization

Citations

This map shows the geographic impact of E C Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E C Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E C Bradley more than expected).

Fields of papers citing papers by E C Bradley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E C Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E C Bradley. The network helps show where E C Bradley may publish in the future.

Co-authorship network of co-authors of E C Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of E C Bradley. A scholar is included among the top collaborators of E C Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E C Bradley. E C Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Bradley, E C, Richard S. Levy, Dinesh Doval, et al.. (2010). Clinical benefit of INCB7839, a potent and selective ADAM inhibitor, in combination with trastuzumab in patients with metastatic HER2+ breast cancer.. Journal of Clinical Oncology. 28(15_suppl). 3025–3025. 33 indexed citations

Campling, Barbara G., Heather M. Baker, Donald L. Greer, et al.. (1992). Establishment and characterization of a panel of human lung cancer cell lines. Cancer. 69(8). 2064–2074. 21 indexed citations

Krigel, Robert L., Kristin Padavic‐Shaller, Alfred R. Rudolph, et al.. (1990). Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon.. Journal of Clinical Oncology. 8(3). 460–467. 36 indexed citations

Bradley, E C, et al.. (1989). Hepatic Resection of Metastasis from Colorectal Carcinoma. Annals of Surgery. 209(4). 428–434. 136 indexed citations

Mitchell, M S, Raymond A. Kempf, W. Harel, et al.. (1989). Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanoma.. PubMed. 65(1). 128–44. 18 indexed citations

Mitchell, M S, Raymond A. Kempf, W. Harel, et al.. (1988). Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected].. Journal of Clinical Oncology. 6(3). 409–424. 155 indexed citations

Whang‐Peng, J., et al.. (1988). Deletion of 3(p14p23) in Secondary Erythroleukemia Arising in Long-Term Survivors of Small Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 80(15). 1253–1255. 10 indexed citations

Borden, Ernest C., E C Bradley, Charles H. Evans, et al.. (1988). Biotechnology products in cancer therapy: a colloquium.. PubMed. 48(1). 223–5. 2 indexed citations

Kay, Neil E., M. M. Oken, J. J. Mazza, & E C Bradley. (1988). Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2.. PubMed. 30(5-6). 475–8. 18 indexed citations

10.

Damle, Nitin K., Laura V. Doyle, J R Bender, & E C Bradley. (1987). Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis.. The Journal of Immunology. 138(6). 1779–1785. 188 indexed citations

11.

Damle, Nitin K., Laura V. Doyle, & E C Bradley. (1986). Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.. The Journal of Immunology. 137(9). 2814–2822. 149 indexed citations

12.

Issell, Brian F., J. J. Catino, & E C Bradley. (1984). Usefulness of the Human Tumor Colony Forming Assay for New Drug Development. Recent results in cancer research. 94. 237–244. 4 indexed citations

13.

Hoff, Daniel D. Von, James T. Casper, E C Bradley, et al.. (1980). Direct cloning of human neuroblastoma cells in soft agar culture.. PubMed. 40(10). 3591–7. 80 indexed citations

14.

Wilson, Floyd D., Katherine A. Stitzel, M. Shifrine, et al.. (1978). Quantitative Response of Bone Marrow Colony-Forming Units (CFU-C and PFU-C) in Weanling Beagles Exposed to Acute Whole-Body γ Irradiation. Radiation Research. 74(2). 289–289. 20 indexed citations

15.

Bradley, E C, et al.. (1976). Measurement of bone density by gas displacement.. PubMed. 11(6). 211–3. 1 indexed citations

16.

Worden, Lee, et al.. (1975). Estimation of effective gamma energy by differential responses of TLD-100 and TLD-200 dosimeters.. PubMed. 28(6). 809–12. 4 indexed citations

17.

Barr, John W. & E C Bradley. (1968). A calibration device for the earpiece dichromatic densitometer.. Journal of Applied Physiology. 25(5). 633–635. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact